Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
432.59
+29.46 (7.31%)
At close: May 12, 2025, 4:00 PM
434.53
+1.94 (0.45%)
After-hours: May 12, 2025, 7:38 PM EDT
Thermo Fisher Market Cap
Thermo Fisher has a market cap or net worth of $163.30 billion as of May 12, 2025. Its market cap has decreased by -25.83% in one year.
Market Cap
163.30B
Enterprise Value
191.61B
1-Year Change
-25.83%
Ranking
Category
Stock Price
$432.59
Market Cap Chart
Since December 1, 1998, Thermo Fisher's market cap has increased from $2.71B to $163.30B, an increase of 5,926.50%. That is a compound annual growth rate of 16.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 152.18B | -23.52% |
Dec 31, 2024 | 198.99B | -2.97% |
Dec 29, 2023 | 205.08B | -5.04% |
Dec 30, 2022 | 215.98B | -17.86% |
Dec 31, 2021 | 262.92B | 42.43% |
Dec 31, 2020 | 184.61B | 41.71% |
Dec 31, 2019 | 130.27B | 44.60% |
Dec 31, 2018 | 90.09B | 18.32% |
Dec 29, 2017 | 76.14B | 36.60% |
Dec 30, 2016 | 55.74B | -1.54% |
Dec 31, 2015 | 56.61B | 12.95% |
Dec 31, 2014 | 50.12B | 24.56% |
Dec 31, 2013 | 40.24B | 75.14% |
Dec 31, 2012 | 22.97B | 35.05% |
Dec 30, 2011 | 17.01B | -22.69% |
Dec 31, 2010 | 22.00B | 13.00% |
Dec 31, 2009 | 19.47B | 36.01% |
Dec 31, 2008 | 14.32B | -40.91% |
Dec 31, 2007 | 24.23B | 238.55% |
Dec 29, 2006 | 7.16B | 46.40% |
Dec 30, 2005 | 4.89B | 1.23% |
Dec 31, 2004 | 4.83B | 17.69% |
Dec 31, 2003 | 4.10B | 24.71% |
Dec 31, 2002 | 3.29B | -22.44% |
Dec 31, 2001 | 4.24B | -20.79% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 659.45B |
Johnson & Johnson | 371.06B |
UnitedHealth Group | 345.29B |
AbbVie | 326.08B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 231.82B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |